498 Bruton’s tyrosine kinase (BTK) inhibitors impede platelet aggregation but not adhesion to collagen.

Míreanna comhchosúla

• Translational autoimmunity in pemphigus and the role of novel Bruton tyrosine kinase inhibitors
  de réir: Piyu Parth Naik
  Foilsithe / Cruthaithe: (2022-01-01)
• Optimization of Azaspirooxindolinone-based PROTACs targeting BTK: Synthesis, kinase profiling, and degradation analysis
  de réir: Naveen Kumar Rampeesa, et al.
  Foilsithe / Cruthaithe: (2026-05-01)
• Inhibition of bruton’s tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis
  de réir: Zhiqiang Xiao, et al.
  Foilsithe / Cruthaithe: (2025-11-01)
• Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways
  de réir: Julie Langlois, et al.
  Foilsithe / Cruthaithe: (2024-10-01)
• Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
  de réir: Gita Manzari Tavakoli, et al.
  Foilsithe / Cruthaithe: (2024-08-01)